Malaria initiative needs drug industry's backing


Play all audios:

Loading...

The pharmaceutical industry must get behind recent efforts by science funding agencies to coordinate an international attack on malaria. Access through your institution Buy or subscribe This


is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 51 print issues and online access $199.00


per year only $3.90 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated


during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support RIGHTS AND PERMISSIONS Reprints and permissions ABOUT


THIS ARTICLE CITE THIS ARTICLE Malaria initiative needs drug industry's backing. _Nature_ 388, 699 (1997). https://doi.org/10.1038/41822 Download citation * Issue Date: 21 August 1997


* DOI: https://doi.org/10.1038/41822 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not


currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative